Sionna Therapeutics (SION) Consolidated Net Income (2024 - 2026)

Quarterly results put Consolidated Net Income at -$26.8 million for Q1 2026, down 60.75% from a year ago — trailing twelve months through Mar 2026 was -$85.8 million (down 28.01% YoY), and the annual figure for FY2025 was -$75.7 million, down 21.32%.

Sionna Therapeutics has reported Consolidated Net Income over the past 3 years, most recently at -$26.8 million for Q1 2026.

  • Consolidated Net Income reached -$26.8 million in Q1 2026 per SION's latest filing, down from -$20.4 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at -$8.7 million in Q2 2024 and bottomed at -$26.8 million in Q1 2026.
  • Median Consolidated Net Income over the past 3 years was -$18.2 million (2025), compared with a mean of -$18.3 million.
  • Peak annual rise in Consolidated Net Income hit 20.61% in 2025, while the deepest fall reached 109.02% in 2025.
  • Over 3 years, Consolidated Net Income stood at -$16.0 million in 2024, then fell by 27.64% to -$20.4 million in 2025, then tumbled by 31.01% to -$26.8 million in 2026.
  • Business Quant data shows Consolidated Net Income for SION at -$26.8 million in Q1 2026, -$20.4 million in Q4 2025, and -$20.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -2.99 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -8.50 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.03 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 727.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -3.40 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 205.99 Mn
10 Sionna Therapeutics 1.87 Bn 1.87 Bn - -26.78 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -26.78 Mn
Dec 31, 2025 -20.44 Mn
Sep 30, 2025 -20.35 Mn
Jun 30, 2025 -18.24 Mn
Mar 31, 2025 -16.66 Mn
Dec 31, 2024 -16.01 Mn
Sep 30, 2024 -25.63 Mn
Jun 30, 2024 -8.73 Mn
Mar 31, 2024 -12.02 Mn